Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 68.83% is in line with its 5-year average of 69.72%, around the middle of its 5-year range (66.60%–72.28%).
0.64% below its 12-month average of 69.27%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 66.60%.
GROSS MARGIN
68.83%
GROSS MARGIN AVG TTM
69.27%
GROSS MARGIN AVG 3Y
69.35%
GROSS MARGIN AVG 5Y
69.72%
GROSS MARGIN AVG 10Y
72.06%
GROSS MARGIN AVG 15Y
76.11%
GROSS MARGIN AVG 20Y
78.47%
CURRENT VS TTM AVG
-0.64%
CURRENT VS 3Y AVG
-0.75%
CURRENT VS 5Y AVG
-1.27%
CURRENT VS 10Y AVG
-4.48%
CURRENT VS 15Y AVG
-9.57%
CURRENT VS 20Y AVG
-12.28%
SECTOR MEDIAN · HEALTHCARE
41.20%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
+67.04%
vs the sector median at left
Myriad Genetics, Inc.
Market Cap
$404.24M
Gross Margin
68.83%
TTM Avg
69.27%
3Y Avg
69.35%
5Y Avg
69.72%
Market Cap
$405.74M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
12.37%
Market Cap
$402.17M
Gross Margin
0.00%
TTM Avg
-125.52%
3Y Avg
-62.76%
5Y Avg
-41.84%
Market Cap
$406.58M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$411.00M
Gross Margin
20.56%
TTM Avg
22.27%
3Y Avg
19.63%
5Y Avg
19.86%
Market Cap
$411.21M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$396.93M
Gross Margin
77.34%
TTM Avg
76.74%
3Y Avg
77.57%
5Y Avg
77.57%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Myriad Genetics, Inc. (MYGN) | $404.24M | 68.83% | 69.27% | 69.35% | 69.72% |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $405.74M | 0.00% | 0.00% | 0.00% | 12.37% |
| Neurogene Inc. (NGNE)vs › | $402.17M | 0.00% | -125.52% | -62.76% | -41.84% |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $406.58M | 0.00% | 0.00% | 0.00% | 0.00% |
| Carlsmed, Inc. (CARL)vs › | $397.99M | 76.63% | 74.56% | 73.66% | 73.66% |
| Strata Critical Medical, Inc. (SRTA)vs › | $411.00M | 20.56% | 22.27% | 19.63% | 19.86% |
| MapLight Therapeutics, Inc. (MPLT)vs › | $411.21M | 0.00% | 0.00% | 0.00% | 0.00% |
| Shoulder Innovations, Inc. (SI)vs › | $396.93M | 77.34% | 76.74% | 77.57% | 77.57% |
| Rezolute, Inc. (RZLT)vs › | $415.98M | 0.00% | 0.00% | 0.00% | 0.00% |
| Senseonics Holdings, Inc. (SENS)vs › | $416.27M | 44.71% | 23.54% | 19.38% | -46.55% |
Gross Margin
68.8%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 66.60% |
| 2026-03-31 | 68.66% |
| 2025-12-31 | 69.97% |
| 2025-09-30 | 69.91% |
| 2025-06-30 | 71.23% |
| 2025-03-31 | 68.50% |
| 2024-12-31 | 71.65% |
| 2024-09-30 | 70.23% |
| 2024-06-30 | 69.55% |
| 2024-03-31 | 68.05% |
| 2023-12-31 | 68.67% |
| 2023-09-30 | 69.98% |
| 2023-06-30 | 68.50% |
| 2023-03-31 | 67.33% |
| 2022-12-31 | 69.69% |
| 2022-09-30 | 67.77% |
| 2022-06-30 | 72.28% |
| 2022-03-31 | 70.89% |
| 2021-12-31 | 71.52% |
| 2021-09-30 | 71.43% |
| 2021-06-30 | 71.65% |
| 2021-03-31 | 70.94% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 69.56% |
| 2020-06-30 | 60.62% |
| 2020-03-31 | 69.45% |
| 2019-12-31 | 74.58% |
| 2019-09-30 | 73.32% |
| 2019-06-30 | 76.51% |
| 2019-03-31 | 77.56% |
| 2018-12-31 | 75.97% |
| 2018-09-30 | 75.43% |
| 2018-06-30 | 76.50% |
| 2018-03-31 | 75.91% |
| 2017-12-31 | 76.37% |
| 2017-09-30 | 75.95% |
| 2017-06-30 | 78.75% |
| 2017-03-31 | 77.50% |
| 2016-12-31 | 77.40% |
| 2016-09-30 | 77.46% |
| 2016-06-30 | 78.54% |
| 2016-03-31 | 78.90% |
| 2015-12-31 | 79.00% |
| 2015-09-30 | 80.11% |
| 2015-06-30 | 79.78% |
| 2015-03-31 | 79.83% |
| 2014-12-31 | 79.45% |
| 2014-09-30 | 79.32% |
| 2014-06-30 | 83.59% |
| 2014-03-31 | 85.45% |
| 2013-12-31 | 87.19% |
| 2013-09-30 | 87.41% |
| 2013-06-30 | 87.32% |
| 2013-03-31 | 87.00% |
| 2012-12-31 | 86.67% |
| 2012-09-30 | 87.01% |
| 2012-06-30 | 87.25% |
| 2012-03-31 | 86.72% |
| 2011-12-31 | 86.88% |
| 2011-09-30 | 87.00% |
| 2011-06-30 | 88.34% |
| 2011-03-31 | 89.13% |
| 2010-12-31 | 88.01% |
| 2010-09-30 | 88.01% |
| 2010-06-30 | 88.01% |
| 2010-03-31 | 88.02% |
| 2009-12-31 | 88.05% |
| 2009-09-30 | 87.00% |
| 2009-06-30 | 86.19% |
| 2009-03-31 | 87.02% |
| 2008-12-31 | 86.83% |
| 2008-09-30 | 86.71% |
| 2008-06-30 | 94.58% |
| 2008-03-31 | 86.62% |
| 2007-12-31 | 86.45% |
| 2007-09-30 | 84.80% |
| 2007-06-30 | 83.28% |
| 2007-03-31 | 81.51% |
| 2006-12-31 | 79.73% |
| 2006-09-30 | 75.84% |
| 2006-06-30 | 74.82% |
| 2006-03-31 | 74.82% |
| 2005-12-31 | 77.05% |
| 2005-09-30 | 76.89% |
| 2005-06-30 | 78.33% |
| 2005-03-31 | 73.46% |
| 2004-12-31 | 73.87% |
| 2004-09-30 | 74.63% |
| 2004-06-30 | 74.56% |
| 2004-03-31 | 73.04% |
| 2003-12-31 | 75.63% |
| 2003-09-30 | 79.83% |
| 2003-06-30 | 79.14% |
| 2003-03-31 | 79.11% |
| 2002-12-31 | 82.40% |
| 2002-09-30 | 81.17% |
